Human CRC cell lines SW620 and COLO205 also demonstrated reduced in vitro proliferation and cyclin D1 protein expression after exposure to CWP232291, a Wnt/β‐catenin inhibitor (JW Pharmaceutical; U.S. patent 8,940,739) (Figure S3A,B).24 The gene discussed is CCND1; the disease is colorectal carcinoma.